{"id":27893,"date":"2024-10-10T09:13:48","date_gmt":"2024-10-10T09:13:48","guid":{"rendered":"https:\/\/www.sib.it\/?p=27893"},"modified":"2025-02-05T11:03:30","modified_gmt":"2025-02-05T11:03:30","slug":"english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division","status":"publish","type":"post","link":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/","title":{"rendered":"SIBprima October 2024  Unified Patent Court Pharma Update &#8211; Imminent infringement &#8211; Milan Central Division"},"content":{"rendered":"<table class=\"alignleft\" style=\"height: 2038px; width: 650px;\" border=\"0 !important\" width=\"650\">\n<tbody>\n<tr style=\"height: 421px;\">\n<td style=\"border-color: #fafafa; height: 421px; width: 650px; text-align: left;\" colspan=\"2\"><img decoding=\"async\" class=\"alignnone size-full wp-image-27895 lazyload\" data-src=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3.png\" alt=\"SIBprima October 2024\" width=\"649\" height=\"405\" data-srcset=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3.png 649w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3-300x187.png 300w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3-150x94.png 150w\" data-sizes=\"(max-width: 649px) 100vw, 649px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 649px; --smush-placeholder-aspect-ratio: 649\/405;\" \/><\/td>\n<\/tr>\n<tr style=\"height: 377px;\">\n<td style=\"border-color: #fafafa; width: 325px; height: 377px; text-align: left;\"><span style=\"color: #000000;\"><strong><span style=\"color: #8a0c0c;\">UPC CASE LAW\u00a0\u00a0<\/span><br \/>\n<\/strong><\/span><\/p>\n<h3><a href=\"https:\/\/sib.arvis.dev\/en\/articles\/imminent-infringement-of-a-medicinal-product-under-upc-rules-an-interesting-decision-of-the-dusseldorf-local-division-c-germinario\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\"><span style=\"color: #000000;\">Imminent infringement of a medicinal product under UPC rules: an interesting decision<\/span><\/span><\/a><\/h3>\n<p><em>Interesting guidance on the the assessment of the &#8220;imminent infringement&#8221; of a pharma patent according to Unified Patent Court law is offered by a recent order of the court&#8217;s D\u00fcsseldorf Local Division, as briefly explained by our Claudio Germinario. <\/em><span style=\"color: #000000;\"><em><span style=\"color: #000000;\">(<a href=\"https:\/\/sib.arvis.dev\/en\/articles\/imminent-infringement-of-a-medicinal-product-under-upc-rules-an-interesting-decision-of-the-dusseldorf-local-division-c-germinario\/\" target=\"_blank\" rel=\"noopener\">more<\/a>)<\/span> <\/em><\/span><\/td>\n<td style=\"border-color: #fafafa; width: 323px; height: 377px; text-align: left;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-27907 lazyload\" data-src=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Siringa-farmaco280.png\" alt=\"\" width=\"263\" height=\"350\" data-srcset=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Siringa-farmaco280.png 263w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Siringa-farmaco280-225x300.png 225w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Siringa-farmaco280-113x150.png 113w\" data-sizes=\"(max-width: 263px) 100vw, 263px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 263px; --smush-placeholder-aspect-ratio: 263\/350;\" \/><\/td>\n<\/tr>\n<tr style=\"height: 381px;\">\n<td style=\"border-color: #fafafa; width: 327px; height: 381px; text-align: left;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-27908 lazyload\" data-src=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Pharma280_2.png\" alt=\"\" width=\"262\" height=\"396\" data-srcset=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Pharma280_2.png 262w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Pharma280_2-198x300.png 198w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Pharma280_2-99x150.png 99w\" data-sizes=\"(max-width: 262px) 100vw, 262px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 262px; --smush-placeholder-aspect-ratio: 262\/396;\" \/><\/td>\n<td style=\"border-color: #fafafa; width: 323px; height: 381px; text-align: left;\"><span style=\"color: #000000;\"><strong><span style=\"color: #8a0c0c;\">UPC INSIGHT\u00a0\u00a0<\/span><br \/>\n<\/strong><\/span><\/p>\n<h3><a href=\"https:\/\/sib.arvis.dev\/en\/flash-news\/the-milan-section-of-the-upcs-central-division-is-up-and-running-a-careful-look-at-its-areas-of-competence\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">A close look at the competence over pharmaceuticals of Milan&#8217;s UPC Central Division<\/span><\/a><\/h3>\n<p><span style=\"color: #000000;\"><em>The areas of competence of the Milan section of the UPC&#8217;s Central Division have been established by a specific amendment of UPC law; as far as pharma patents are concerned, Milan\u2019s competences may be broader than they appear at first glance, depending on how the wording of relevant UPC laws and rules of procedure is interpreted. (<span style=\"color: #000000;\"><a href=\"https:\/\/sib.arvis.dev\/en\/flash-news\/the-milan-section-of-the-upcs-central-division-is-up-and-running-a-careful-look-at-its-areas-of-competence\/\" target=\"_blank\" rel=\"noopener\">more<\/a><\/span>) <\/em><\/span><\/td>\n<\/tr>\n<tr style=\"height: 228px;\">\n<td style=\"border-color: #fafafa; width: 327px; height: 228px; text-align: left;\"><span style=\"color: #000000;\"><span style=\"color: #8a0c0c;\"><strong><span style=\"color: #800000;\">EVENTS WITH SIB\/1<\/span><br \/>\n<\/strong><\/span><\/span><\/p>\n<h3><a href=\"https:\/\/sib.arvis.dev\/en\/events\/see-you-at-the-aipla-2024-annual-meeting\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">Attending the AIPLA 2024 Annual Meeting<\/span><\/a><\/h3>\n<p><em>Our pertner Elisabetta Papa, Sofia Santoro and Benedetta Soranzo are attending the AIPLA 2024 Annual Meeting taking place at the Gaylord National Resort. (<a href=\"https:\/\/sib.arvis.dev\/en\/events\/see-you-at-the-aipla-2024-annual-meeting\/\" target=\"_blank\" rel=\"noopener\">more<\/a>)<\/em><\/td>\n<td style=\"border-color: #fafafa; width: 323px; text-align: left; vertical-align: top; height: 228px;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-27910 lazyload\" data-src=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/AIPLA-Ann-Meeting-2024_280.png\" alt=\"\" width=\"280\" height=\"280\" data-srcset=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/AIPLA-Ann-Meeting-2024_280.png 280w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/AIPLA-Ann-Meeting-2024_280-150x150.png 150w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/AIPLA-Ann-Meeting-2024_280-45x45.png 45w\" data-sizes=\"(max-width: 280px) 100vw, 280px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 280px; --smush-placeholder-aspect-ratio: 280\/280;\" \/><\/td>\n<\/tr>\n<tr style=\"height: 439px;\">\n<td style=\"border-color: #fafafa; width: 327px; height: 444px; border-style: solid; text-align: left; vertical-align: top;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-27911 lazyload\" data-src=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/AIPPI-2024-World-Cong280.png\" alt=\"\" width=\"280\" height=\"280\" data-srcset=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/AIPPI-2024-World-Cong280.png 280w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/AIPPI-2024-World-Cong280-150x150.png 150w, https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/AIPPI-2024-World-Cong280-45x45.png 45w\" data-sizes=\"(max-width: 280px) 100vw, 280px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 280px; --smush-placeholder-aspect-ratio: 280\/280;\" \/><\/td>\n<td style=\"border-color: #fafafa; width: 323px; text-align: left; vertical-align: top; height: 444px; border-style: solid;\"><span style=\"color: #000000;\"><span style=\"color: #8a0c0c;\"><strong><span style=\"color: #800000;\">EVENTS WITH SIB\/2<\/span><\/strong><\/span><\/span><\/p>\n<h3><a href=\"https:\/\/sib.arvis.dev\/en\/events\/see-you-at-the-aippi-world-congress-in-hangzhou-china\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">See you at the AIPPI World Congress in Hangzhou, China<\/span><\/a><\/h3>\n<p><em>Our partner Andrea Soldatini and Alberto De Ros are looking forward to taking part in the AIPPI World Congress 2024. (<a href=\"https:\/\/sib.arvis.dev\/en\/events\/see-you-at-the-aippi-world-congress-in-hangzhou-china\/\" target=\"_blank\" rel=\"noopener\">more<\/a>)<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>\u00a0<\/strong><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UPC CASE LAW\u00a0\u00a0 Imminent infringement of a medicinal product under UPC rules: an interesting decision Interesting guidance on the the assessment of the &#8220;imminent infringement&#8221; of a pharma patent according to Unified Patent Court law is offered by a recent order of the court&#8217;s D\u00fcsseldorf Local Division, as briefly explained by our Claudio Germinario. (more) [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":27895,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[16],"tags":[],"class_list":["post-27893","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsletter"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SIBprima April 2024<\/title>\n<meta name=\"description\" content=\"SIBprima April 2024 - The AI Act and IP - Italy and the European Patent - EPO fee reduction - New EU rules for GIs - SIB wins 4 Managing IP trophies\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SIBprima April 2024\" \/>\n<meta property=\"og:description\" content=\"SIBprima April 2024 - The AI Act and IP - Italy and the European Patent - EPO fee reduction - New EU rules for GIs - SIB wins 4 Managing IP trophies\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-10T09:13:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T11:03:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"649\" \/>\n\t<meta property=\"og:image:height\" content=\"405\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Laura Ercoli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laura Ercoli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/\"},\"author\":{\"name\":\"Laura Ercoli\",\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/#\\\/schema\\\/person\\\/3988cde84153da4b745510f0712d395b\"},\"headline\":\"SIBprima October 2024 Unified Patent Court Pharma Update &#8211; Imminent infringement &#8211; Milan Central Division\",\"datePublished\":\"2024-10-10T09:13:48+00:00\",\"dateModified\":\"2025-02-05T11:03:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/\"},\"wordCount\":213,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sib.arvis.dev\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Copertina_def3.png\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/\",\"url\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/\",\"name\":\"SIBprima April 2024\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sib.arvis.dev\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Copertina_def3.png\",\"datePublished\":\"2024-10-10T09:13:48+00:00\",\"dateModified\":\"2025-02-05T11:03:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/#\\\/schema\\\/person\\\/3988cde84153da4b745510f0712d395b\"},\"description\":\"SIBprima April 2024 - The AI Act and IP - Italy and the European Patent - EPO fee reduction - New EU rules for GIs - SIB wins 4 Managing IP trophies\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sib.arvis.dev\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Copertina_def3.png\",\"contentUrl\":\"https:\\\/\\\/sib.arvis.dev\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/Copertina_def3.png\",\"width\":649,\"height\":405,\"caption\":\"SIBprima October 2024\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/newsletter\\\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/home\\\/?lang=en\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"(English) SIBprima October 2024 Unified Patent Court Pharma Update &#8211; Imminent infringement &#8211; Milan Central Division\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/\",\"name\":\"\",\"description\":\"Intellectual Property since 1882\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/#\\\/schema\\\/person\\\/3988cde84153da4b745510f0712d395b\",\"name\":\"Laura Ercoli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b585753dc2b199a95f18adfc63fe4f51a86794b5f62f6d6087ebb3cbe49a1fbc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b585753dc2b199a95f18adfc63fe4f51a86794b5f62f6d6087ebb3cbe49a1fbc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b585753dc2b199a95f18adfc63fe4f51a86794b5f62f6d6087ebb3cbe49a1fbc?s=96&d=mm&r=g\",\"caption\":\"Laura Ercoli\"},\"url\":\"https:\\\/\\\/sib.arvis.dev\\\/en\\\/author\\\/lercoli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SIBprima April 2024","description":"SIBprima April 2024 - The AI Act and IP - Italy and the European Patent - EPO fee reduction - New EU rules for GIs - SIB wins 4 Managing IP trophies","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"SIBprima April 2024","og_description":"SIBprima April 2024 - The AI Act and IP - Italy and the European Patent - EPO fee reduction - New EU rules for GIs - SIB wins 4 Managing IP trophies","og_url":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/","article_published_time":"2024-10-10T09:13:48+00:00","article_modified_time":"2025-02-05T11:03:30+00:00","og_image":[{"width":649,"height":405,"url":"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3.png","type":"image\/png"}],"author":"Laura Ercoli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Laura Ercoli","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/#article","isPartOf":{"@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/"},"author":{"name":"Laura Ercoli","@id":"https:\/\/sib.arvis.dev\/en\/#\/schema\/person\/3988cde84153da4b745510f0712d395b"},"headline":"SIBprima October 2024 Unified Patent Court Pharma Update &#8211; Imminent infringement &#8211; Milan Central Division","datePublished":"2024-10-10T09:13:48+00:00","dateModified":"2025-02-05T11:03:30+00:00","mainEntityOfPage":{"@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/"},"wordCount":213,"commentCount":0,"image":{"@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/#primaryimage"},"thumbnailUrl":"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3.png","articleSection":["Newsletter"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/","url":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/","name":"SIBprima April 2024","isPartOf":{"@id":"https:\/\/sib.arvis.dev\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/#primaryimage"},"image":{"@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/#primaryimage"},"thumbnailUrl":"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3.png","datePublished":"2024-10-10T09:13:48+00:00","dateModified":"2025-02-05T11:03:30+00:00","author":{"@id":"https:\/\/sib.arvis.dev\/en\/#\/schema\/person\/3988cde84153da4b745510f0712d395b"},"description":"SIBprima April 2024 - The AI Act and IP - Italy and the European Patent - EPO fee reduction - New EU rules for GIs - SIB wins 4 Managing IP trophies","breadcrumb":{"@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/#primaryimage","url":"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3.png","contentUrl":"https:\/\/sib.arvis.dev\/wp-content\/uploads\/2024\/10\/Copertina_def3.png","width":649,"height":405,"caption":"SIBprima October 2024"},{"@type":"BreadcrumbList","@id":"https:\/\/sib.arvis.dev\/en\/newsletter\/english-sibprima-october-2024-unified-patent-court-pharma-update-imminent-infringement-of-a-pharma-patent-competence-over-pharmaceuticals-of-milans-central-division\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sib.arvis.dev\/en\/home\/?lang=en"},{"@type":"ListItem","position":2,"name":"(English) SIBprima October 2024 Unified Patent Court Pharma Update &#8211; Imminent infringement &#8211; Milan Central Division"}]},{"@type":"WebSite","@id":"https:\/\/sib.arvis.dev\/en\/#website","url":"https:\/\/sib.arvis.dev\/en\/","name":"","description":"Intellectual Property since 1882","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sib.arvis.dev\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/sib.arvis.dev\/en\/#\/schema\/person\/3988cde84153da4b745510f0712d395b","name":"Laura Ercoli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b585753dc2b199a95f18adfc63fe4f51a86794b5f62f6d6087ebb3cbe49a1fbc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b585753dc2b199a95f18adfc63fe4f51a86794b5f62f6d6087ebb3cbe49a1fbc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b585753dc2b199a95f18adfc63fe4f51a86794b5f62f6d6087ebb3cbe49a1fbc?s=96&d=mm&r=g","caption":"Laura Ercoli"},"url":"https:\/\/sib.arvis.dev\/en\/author\/lercoli\/"}]}},"_links":{"self":[{"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/posts\/27893","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/comments?post=27893"}],"version-history":[{"count":14,"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/posts\/27893\/revisions"}],"predecessor-version":[{"id":28667,"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/posts\/27893\/revisions\/28667"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/media\/27895"}],"wp:attachment":[{"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/media?parent=27893"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/categories?post=27893"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sib.arvis.dev\/en\/wp-json\/wp\/v2\/tags?post=27893"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}